SLC22A1 and breast cancer: Ten sulfonamide metformin derivatives that differ in a number and position of alkyl substituents in the benzene ring (compounds 1–10) were comprehensively studied in two unmodified breast cancer cell lines, MCF-7 and MDA-MB-231 differing with the expression of OCT1-3 transporters on their surface.